Efavirenz Suppliers & Bulk Manufacturers
Available Forms: Tablet & Capsule
Available Strengths: Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg
Reference Brands: Sustiva®(US); Stocrin®(EU)
Category: Anti Viral
Efavirenz Tablets, a key NNRTI for HIV treatment, are available in 200 mg and 600 mg strengths. PharmaB2B connects global buyers with certified manufacturers offering bulk supply and fixed-dose combos like Atripla. Ideal for compliant sourcing in tenders, HIV programs, and international pharmaceutical trade.
Product Description:
Efavirenz Tablets are widely used as part of combination therapy for HIV-1 treatment, classified under NNRTIs. Commonly available in 600 mg and pediatric strengths, Efavirenz is also found in fixed-dose combinations like Atripla®. On PharmaB2B platforms, bulk buyers and distributors can connect with GMP-certified manufacturers for high-quality Efavirenz products. Ideal for hospitals, HIV programs, NGOs, and government tenders, PharmaB2B supports cost-effective and compliant procurement across global markets. Whether sourcing single or combo formulations, buyers benefit from reliable supply chains and competitive pricing. Choose PharmaB2B for trusted suppliers of Efavirenz and other essential antiretrovirals.
Efavirenz — third party manufacturing & bulk supply
Efavirenz is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Efavirenz listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Efavirenz →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Efavirenz is used to treat HIV-1 infection. It helps reduce viral load and improve immune function by blocking the HIV reverse transcriptase enzyme. It is typically used as part of combination antiretroviral therapy.
Efavirenz is made from the active non-nucleoside reverse transcriptase inhibitor (NNRTI) compound efavirenz, a synthetic benzoxazinone derivative.
The well-known trade name is Sustiva.
Sustiva is manufactured by Bristol-Myers Squibb (BMS). Many generic pharmaceutical companies worldwide also produce efavirenz.
The generic name is efavirenz.
The primary brand name is Sustiva.
Efavirenz is manufactured in approved facilities across the USA, Europe, and India, depending on whether it is the innovator brand or a generic version.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
